Retraction: Abdallah MS, Mosalam EM, Hassan A, et al. Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial. CNS Neurosci. Ther. 2023;29:354-364 (https://doi.org/10.1111/cns.14010)
- PMID: 38465469
- PMCID: PMC10926048
- DOI: 10.1111/cns.14668
Retraction: Abdallah MS, Mosalam EM, Hassan A, et al. Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial. CNS Neurosci. Ther. 2023;29:354-364 (https://doi.org/10.1111/cns.14010)
Abstract
Retraction: Abdallah MS, Mosalam EM, Hassan A, et al. Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial. CNS Neurosci. Ther. 2023;29:354-364 (https://doi.org/10.1111/cns.14010) The above article, published online on November 07, 2022 in Wiley Online Library (wileyonlinelibrary.com) has been retracted by agreement between the journal's Editor-in-Chief, Xiaoming Hu, and John Wiley and Sons Ltd. Following publication, the Editor-in-Chief raised concerns about the integrity of the clinical trial. An investigation revealed significant issues regarding the reliability of the reported data. As a result, the Editor-in-Chief no longer has confidence in the validity of the results presented in this article.
© 2024 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.
Retraction of
-
Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial.CNS Neurosci Ther. 2023 Jan;29(1):354-364. doi: 10.1111/cns.14010. Epub 2022 Nov 7. CNS Neurosci Ther. 2023. Retraction in: CNS Neurosci Ther. 2024 Mar;30(3):e14668. doi: 10.1111/cns.14668 PMID: 36341700 Free PMC article. Retracted. Clinical Trial.
Similar articles
-
Retraction: Abdallah MS, Mosalam EM, Hassan A, et al. Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial. CNS Neurosci. Ther. 2023;29:354-364 (https://doi.org/10.1111/cns.14010).CNS Neurosci Ther. 2024 Mar;30(3):e14667. doi: 10.1111/cns.14667. CNS Neurosci Ther. 2024. PMID: 38465461 Free PMC article.
-
Retraction.Cancer Sci. 2023 Jul;114(7):3057. doi: 10.1111/cas.15809. Epub 2023 May 22. Cancer Sci. 2023. PMID: 37211924 Free PMC article.
-
Retraction.Cancer Med. 2023 May;12(9):11041. doi: 10.1002/cam4.5823. Epub 2023 Apr 12. Cancer Med. 2023. PMID: 37050853 Free PMC article.
-
Retraction.Int J Gynaecol Obstet. 2023 Sep;162(3):1127. doi: 10.1002/ijgo.14980. Epub 2023 Jun 26. Int J Gynaecol Obstet. 2023. PMID: 37358060
-
Retracted: Endometrial scratch injury in infertile women seeking conception through natural or intrauterine insemination cycles: A systematic review and meta-analysis.Int J Gynaecol Obstet. 2023 Aug;162(2):785. doi: 10.1002/ijgo.14030. Epub 2021 Dec 5. Int J Gynaecol Obstet. 2023. Retraction in: Int J Gynaecol Obstet. 2023 May 12. doi: 10.1002/ijgo.14858 PMID: 34787914 Retracted. Review.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
